NBP - NovaBridge Biosciences News

Sectors

NBP

NovaBridge Biosciences

1.82

2 x 1.19

2 x 2.08

bid

ask

0.02

1.09%

2 @ 07:30 PM

1.83 +0.01 (0.82%)

Ytd	-54.27%
1y	-56.25%

1.80

day range

1.86

1.46

52 week range

6.79

Open	1.81	Prev Close	1.84	Low	1.80	High	1.86	Mkt Cap	210.48M
Vol	273.73K	Avg Vol	470.87K	EPS	-0.69	P/E	N/A	Forward P/E	N/A
Beta	1.47	Short Ratio	N/A	Inst. Own	N/A	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	08-20	50-d Avg	1.81	200-d Avg	2.76	1yr Est	0.00

NBP News

globenewswire.com

NovaBridge Biosciences to Participate in September Investor Conferences

ROCKVILLE, Md., Aug. 27, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge”

benzinga.com

HC Wainwright & Co. Reiterates Buy on NovaBridge Biosciences, Maintains $9 Price Target

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates NovaBridge Biosciences (NASDAQ:NBP

seekingalpha.com

NovaBridge Biosciences (NBP) Q2 2026 Earnings Call Transcript

benzinga.com

NovaBridge Biosciences H1 EPS $(0.33) Misses $(0.14) Estimate

NovaBridge Biosciences (NASDAQ:NBP) reported quarterly losses of $(0.33) per share which missed the

globenewswire.com

NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic

ROCKVILLE, Md., Aug. 20, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge”

globenewswire.com

NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, A

ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge”

gurufocus.com

Woodside Energy Second Quarter Report for Period Ended 30 June 2026

Woodside Energy Group (ASX: WDS) (NYSE: WDS):2026 full-year guidancePriorCurrentTotal production vol

globenewswire.com

NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026

ROCKVILLE, Md., July 24, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge”

defenseworld.net

I-Mab (NASDAQ:NBP) Trading Down 4.9% – Time to Sell?

Shares of I-Mab (NASDAQ: NBP - Get Free Report) dropped 4.9% during mid-day trading on Wednesday. Th

benzinga.com

NovaBridge Names Srishti Gupta CEO As Sean Fu Steps Down

NovaBridge Biosciences (NASDAQ:NBP) ("NovaBridge" or the "Company"), a clinical-stag

globenewswire.com

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge”

benzinga.com

NovaBridge Biosciences Says FDA Grants Fast Track Designation To Givastomig In First-Line HER2-Negat

Registrational Phase 3 Trial Expected to Begin as Early as Q4 2026Detailed Phase 1b Data Expected to

globenewswire.com

NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negativ

Registrational Phase 3 Trial Expected to Begin as Early as Q4 2026 Detailed Phase 1b Data Expected t

globenewswire.com

NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference

ROCKVILLE, Md., May 28, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or

globenewswire.com

NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference

ROCKVILLE, Md., May 12, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or

benzinga.com

Alpha Buying: Insider Conviction in High-Risk Biotech

benzinga.com

12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com

NovaBridge Biosciences Appoints Mark Hagler As President And Chief Commercial Officer

Seasoned Biopharma leader bringing deep commercial experience to shape and inform corporate strategy

globenewswire.com

NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Stra

Seasoned Biopharma leader bringing deep commercial experience to shape and inform corporate strategy

seekingalpha.com

NovaBridge's Givastomig Could Drive A Major Re-Rating

NovaBridge Biosciences remains a high-risk, catalyst-driven biotech, trading near cash value with a

benzinga.com

HC Wainwright & Co. Reiterates Buy on NovaBridge Biosciences, Maintains $9 Price Target

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates NovaBridge Biosciences (NASDAQ:NBP

globenewswire.com

NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update

ROCKVILLE, Md., April 07, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge

benzinga.com

HC Wainwright & Co. Reiterates Buy on NovaBridge Biosciences, Maintains $9 Price Target

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates NovaBridge Biosciences (NASDAQ:NBP

globenewswire.com

NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Giv

FDA confirmed givastomig's potential eligibility for an accelerated approval pathway NovaBridge expe

seekingalpha.com

NovaBridge Biosciences (NBP) Discusses Phase 2a Clinical Data and Development Plan for VIS-101 in We

benzinga.com

Mid-Cap NovaBridge Biosciences Stock Jumps Fueled By Positive Study Data In Eye Disease

NovaBridge Biosciences (NASDAQ: NBP) shares are up on Monday following the announcement of positive

benzinga.com

Mid-Cap NovaBridge Biosciences Stock Jumps Fueled By Positive Study Data In Eye Disease

NovaBridge stock jumps after VIS-101 Phase 2a study shows strong vision improvement in wet age-relat

benzinga.com

Novabridge Biosciences' Topline Results From The Phase 2A Study Of VIS-101 For Retinal Vascular Dise

VIS-101, purpose-designed to be best-in-class for retinal vascular diseases, is a tetravalent, dual

globenewswire.com

NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study

ROCKVILLE, Md., March 09, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge

benzinga.com

Ooma, John Wiley & Sons, Okta And Other Big Stocks Moving Higher On Thursday

Ooma (NYSE:OOMA) shares rose 11.3% after beating Q4 earnings and revenue expectations. Other gainers

globenewswire.com

NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, Ma

VIS-101, purpose-designed to be a best-in-class dual VEGF-A/ANG-2 inhibitor, has the potential to pr

globenewswire.com

NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference

ROCKVILLE, Md., March 02, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge

benzinga.com

NovaBridge Biosciences Doses First Participant In Phase 2 Combination Trial Of Givastomig With Nivol

NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform com

benzinga.com

12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com

Amazon To $300? Here Are 10 Top Analyst Forecasts For Friday

benzinga.com

HC Wainwright & Co. Maintains Buy on NovaBridge Biosciences, Raises Price Target to $9

HC Wainwright & Co. analyst Andres Y. Maldonado maintains NovaBridge Biosciences (NASDAQ:NBP)

benzinga.com

NovaBridge Executive Chairman Fu Wei Plans Open-Market Purchase of Up to $5M in Stock After Positive

NovaBridge Biosciences (NASDAQ:NBP) (NovaBridge or the Company) a global biotechnology platform comp

benzinga.com

What's Going On With NovaBridge Stock Tuesday?

NovaBridge stock was trading higher Tuesday but has since reversed and begun trading lower. NovaBrid

benzinga.com

NovaBridge Highlights Phase 1b Givastomig Combination Results With Strong Responses And Manageable S

Givastomig, a CLDN18.2 x 4-1BB bispecific antibody, continues to show robust efficacy when combined

benzinga.com

12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com

Reported Earlier, NovaBridge Highlights Ragistomig 4-1BB X PD-L1 Bispecific Antibody For Patients Re

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or re

benzinga.com

12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Tuesday's After-Market Session